Aridis' Monoclonal Antibody Rouses Analyst Optimism Despite Pneumonia Phase III Miss

Trial Size Limited

Paper lungs with red pills underneath on light blue background
Aridis' Drug Candidate Could Help 250,000 US Patients Each Year • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Clinical Trials

More from R&D